V017-1754 Screening compound: N-[2-(MORPHOLIN-4-YL)ETHYL]-N-{[3-PHENYL-5-(PYRROLIDIN-1-YL)-1,2-OXAZOL-4-YL]METHYL}CYCLOPROPANECARBOXAMIDE

V017-1754 Screening compound: N-[2-(MORPHOLIN-4-YL)ETHYL]-N-{[3-PHENYL-5-(PYRROLIDIN-1-YL)-1,2-OXAZOL-4-YL]METHYL}CYCLOPROPANECARBOXAMIDE
V017-1754 Screening compound: N-[2-(MORPHOLIN-4-YL)ETHYL]-N-{[3-PHENYL-5-(PYRROLIDIN-1-YL)-1,2-OXAZOL-4-YL]METHYL}CYCLOPROPANECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V017-1754
N-[2-(MORPHOLIN-4-YL)ETHYL]-N-{[3-PHENYL-5-(PYRROLIDIN-1-YL)-1,2-OXAZOL-4-YL]METHYL}CYCLOPROPANECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V017-1754

Molecular Formula

C24H32N4O3 (C24 H32 N4 O3)

Compound Name

N-[2-(MORPHOLIN-4-YL)ETHYL]-N-{[3-PHENYL-5-(PYRROLIDIN-1-YL)-1,2-OXAZOL-4-YL]METHYL}CYCLOPROPANECARBOXAMIDE

IUPAC name

n/a

SMILES

O=C(C1CC1)N(CCN1CCOCC1)Cc1c(N2CCCC2)onc1-c1ccccc1

InChI

InChI=1S/C24H32N4O3/c29-23(20-8-9-20)28(13-12-26-14-16-30-17-15-26)18-21-22(19-6-2-1-3-7-19)25-31-24(21)27-10-4-5-11-27/h1-3,6-7,20H,4-5,8-18H2

InChI Key

IZQWTCOXFXKRHC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19883263

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

424.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.782

Distribution Coefficient, logD

2.762

Water Solubility, LogSw

-2.84

Polar Surface Area

55.235

Acid Dissociation Constant (pKa)

22.33

Base Dissociation Constant (pKb)

6.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

58.30

V017-1754 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V017-1754 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V017-1754?
Check Price and Availability of V017-1754, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V017-1754 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V017-1754
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V017-1754
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V017-1754 available by request